These results suggest that the ectopically expressed TSPY could exacerbate oncogenesis and progression in HCC by stimulating downstream unfavorable (pro-oncogenic) but repressing favorable (anti-oncogenic) gene expression in the tumors. The gene discussed is TSPY1; the disease is hepatocellular carcinoma.